Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

8 treatments under study, led by Glucosamine Tablet Without Liposomal

Related Conditions

Often studied with 4 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 3 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

3Total
Not Applicable (3)

Trial Status

Completed2
Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 2 completed trials

Clinical Trials (3)

Showing 3 of 3 trials
NCT07843342Not ApplicableRecruiting

Human Absorption Study of Liposomal Glucosamine Supplements

NCT07804758Not ApplicableCompleted

Ultra-Micronized vs Liposomal PEA 600 mg: A Crossover PK Study in Healthy Subjects

NCT06771388Not ApplicableCompleted

Efficacy Evaluation of Avance QQ Collagen for Skin Beautification

Showing all 3 trials

Research Network

Common Treatments

  • Glucosamine Tablet Without Liposomal1
  • Ultramicronised Pea1
  • Glucosamine Liquid Without Liposomal1
  • Highemulsified Liposomal Glucosamine Liquid1
  • Liposomal Collagen Drink1

Active Sponsors

  • TCI Co., Ltd.2
  • S&R Farmaceutici S.p.A.1

Top Investigators

Related Conditions

  • Pk In Healthy Volunteers1
  • Palmitoylethanolamide1
  • Skin Condition1
  • Glucosamine1

Activity Timeline